CCNE1 amplification indicates highly-aggressive component and suppressed immune status among different carcinomas

CCNE1 amplification (CCA) is a critical molecular alteration in tumors and a potential targetable for emerging therapies, however, its pan-cancer clinicopathological features and tumor immune microenvironment (TIME) characteristics remain poorly defined. This study compared CCA and non-amplified tumors across lung (LUAD), gastric (GA), ovarian (OV), and uterine (UC) carcinomas using our institutional cohort (n = 433) and public datasets (TCGA/cBioPortal), integrating histopathology, multi-omics, and detection validation (NGS/FISH/IHC). CCA exhibited aggressive histologic differentiation across tumor types, including the primitive enterocyte phenotype in GA, high-grade serous carcinoma/carcinosarcoma in UC/OV, and frequent neuroendocrine transformation in recurrent LUAD. All CCA groups had worse prognoses than their non-amplified counterparts. Cellular experiments validated the phenotypic transformation and unregulated proliferation following CCNE1 overexpression. Single-cell spatial transcriptomics and IHC revealed an immunosuppressive TIME across tumor types. Moreover, dual-color FISH demonstrated optimal detection consistency. This multi-cancer, multi-omics analysis establishes CCNE1 amplification as a hallmark of aggressive, immunoevasive carcinomas. This study integrated CCNE1-amplified carcinoma (CCA) pathological differentiation features across multiple cancer types from a histopathological perspective, breaking through single-organ limitations. In multiple cancer types, CCNE1 amplification indicates enhanced aggressiveness. Single-cell spatial transcriptomics was employed to analyze the tumor immune microenvironment characteristics of CCA.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2026-11-13
DOI
https://doi.org/10.1186/s12967-026-09156-0
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CCNE1 amplification indicates highly-aggressive component and suppressed immune status among different carcinomas

Jianming Ying, Jiali Mu, Zuxuan Zhao, Liyan Xue et al.
5 links
Journal of Translational Medicine
Cancer Genomics and Diagnostics
article

CCNE1 amplification indicates highly-aggressive component and suppressed immune status among different carcinomas

Jianming Ying, Jiali Mu, Zuxuan Zhao, Liyan Xue, Fanshuang Zhang, Ziyang Zhou, Zihan Sun, Lina Gao, Weihua Li, Bingzhi Wang, Shun Wang, Hong Zhao, Lei Guo, Shuhang Wang
article en

Abstract

CCNE1 amplification (CCA) is a critical molecular alteration in tumors and a potential targetable for emerging therapies, however, its pan-cancer clinicopathological features and tumor immune microenvironment (TIME) characteristics remain poorly defined. This study compared CCA and non-amplified tumors across lung (LUAD), gastric (GA), ovarian (OV), and uterine (UC) carcinomas using our institutional cohort (n = 433) and public datasets (TCGA/cBioPortal), integrating histopathology, multi-omics, and detection validation (NGS/FISH/IHC). CCA exhibited aggressive histologic differentiation across tumor types, including the primitive enterocyte phenotype in GA, high-grade serous carcinoma/carcinosarcoma in UC/OV, and frequent neuroendocrine transformation in recurrent LUAD. All CCA groups had worse prognoses than their non-amplified counterparts. Cellular experiments validated the phenotypic transformation and unregulated proliferation following CCNE1 overexpression. Single-cell spatial transcriptomics and IHC revealed an immunosuppressive TIME across tumor types. Moreover, dual-color FISH demonstrated optimal detection consistency. This multi-cancer, multi-omics analysis establishes CCNE1 amplification as a hallmark of aggressive, immunoevasive carcinomas. This study integrated CCNE1-amplified carcinoma (CCA) pathological differentiation features across multiple cancer types from a histopathological perspective, breaking through single-organ limitations. In multiple cancer types, CCNE1 amplification indicates enhanced aggressiveness. Single-cell spatial transcriptomics was employed to analyze the tumor immune microenvironment characteristics of CCA.

Journal of Translational Medicine
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), China-Japan Friendship Hospital (CN), Cancer Hospital of Chinese Academy of Medical Sciences (CN), State Key Laboratory of Molecular Oncology (CN)
Good health and well-being
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon